Lloyd Carney is Director of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 6,319 shares of VRTX, which is worth approximately $2.88 Million. The most recent transaction as insider was on May 01, 2024, when has been sold 1,001 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.32K
18.82% 3M change
18.82% 12M change
Total Value Held $2.88 Million

LLOYD CARNEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2024
BUY
Grant, award, or other acquisition
-
1,001 Added 13.67%
6,319 Common Stock
May 01 2023
BUY
Grant, award, or other acquisition
-
1,168 Added 18.01%
5,318 Common Stock
Jan 30 2023
SELL
Open market or private sale
$866,349 $320.87 p/Share
2,700 Reduced 39.42%
4,150 Common Stock
May 01 2022
BUY
Grant, award, or other acquisition
-
1,449 Added 17.46%
6,850 Common Stock
May 01 2021
BUY
Grant, award, or other acquisition
-
1,842 Added 25.43%
5,401 Common Stock

Also insider at

V
VISA INC. Financial Services
GDYN
GRID DYNAMICS HOLDINGS, INC. Technology
NUAN
Nuance Communications, Inc. Technology
LC

Lloyd Carney

Director
San Francisco, CA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX